Swiss hospital launches 20-year hunt for superbug patterns

NCT ID NCT04098133

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at patients infected with carbapenemase-producing bacteria (CPB), a type of superbug resistant to many antibiotics. Researchers will track 100 patients over 20 years to see how often these infections occur, how quickly they are detected, and what factors increase risk. The goal is to improve infection control and treatment timing, not to test a new drug.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help hospitals better detect and control dangerous, drug-resistant bacteria, potentially reducing infection spread.

What could go wrong

This is an observational study, not a treatment trial. It will not directly cure or prevent infections, and results may not apply to other hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTIONS WITH CPB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Division of Infectious Diseases and Hospital Epidemiology

    RECRUITING

    Basel, 4031, Switzerland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••